Luxembourg Institute of Health (LIH)
Luxembourg Institute of Health (LIH)
Strassen, Luxembourg

Luxembourg Institute of Health (LIH)

Mission & Vision

Luxembourg Institute of Health is a public biomedical research organisation. Striving for excellence, its researchers, by their creativity, enthusiasm and commitment, generate knowledge on disease mechanisms and contribute to the development of new diagnostics, preventive strategies, innovative therapies and clinical applications that impact the healthcare of Luxembourgish and European citizens.

Our Boards

The Executive Committee is responsible for the implementation of the strategy approved by the board of administration. It guarantees the compliance with ethical principles, conventions and national laws.

The Board of Directors oversees the work of the Luxembourg Institute of Health. It is responsible for the general organization, for budget control, for framework contracts with partner organisations and for approving new strategy.

The Scientific Advisory Boards (SAB) are consultative bodies to the Board of Administration and are composed of high ranking external scientists.  The SABs’ composition reflects the scientific areas in which the Luxembourg Institute of Health is active.

2 JOBS FROM THIS EMPLOYER

Luxembourg Institute of Health (LIH)
Luxembourg Institute of Health (LIH)
Location: Strassen, Luxembourg | Closing on Sep 15
PROJECT MANAGER for a new Center of Excellence in Digital Health and Personalized Medicine (m/f)
In the context of a project funded through the EU Horizon 2020 Framework Programme for Research and Innovation addressing future clinical and societal needs in the Luxembourgish healthcare and biomedical research landscape, Professor Markus Ollert, Director of the Department of...
Luxembourg Institute of Health (LIH)
Luxembourg Institute of Health (LIH)
Location: Strassen, Luxembourg | Closing on Aug 31
Post-Doctoral Researcher in Proteomics (m/f)
Deregulated signaling of receptor tyrosine kinases (RTK) are a hallmark of glioblastomas (GBM) and many therapeutic attempts are undertaken to interfere with hyperactive intracellular signaling. Attempts to map the exact phosphorylation status of the RTK substrates is hampered...